5 Key Takeaways

• 1

  Alcon has launched the Voyager DSLT, an automated Nd:YAG laser for direct selective laser trabeculoplasty, now available in the U.S.

• 2

  The Voyager DSLT eliminates the need for contact procedures like gonioscopy, enhancing patient comfort and ergonomics.

• 3

  Clinical data shows Voyager DSLT is noninferior to traditional SLT at 6 months, with excellent efficacy and safety up to 12 months.

• 4

  The Voyager DSLT addresses the growing need for efficient laser trabeculoplasty as a primary therapy for open-angle glaucoma.

• 5

  Dr. Nathan Radcliffe emphasizes the importance of integrating Voyager DSLT into practice to improve interventional glaucoma treatment.